Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Hahn Mark W

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerFeb 01, 2024Option Exercise$2.29480,6641,102,54715,031,576Feb 05, 2024, 06:09 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerNov 01, 2023Option Exercise$1.74809,0081,410,74815,512,240Nov 03, 2023, 08:08 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 04, 2023Sale$2.50150,000374,88015,529,864Aug 07, 2023, 09:17 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 07, 2023Sale$2.478,61621,26315,521,248Aug 07, 2023, 09:17 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 03, 2023Sale$2.54117,272297,75415,679,864Aug 07, 2023, 09:17 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 01, 2023Sale$2.68105,944283,82415,870,840Aug 03, 2023, 08:31 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 02, 2023Sale$2.5973,704191,11415,797,136Aug 03, 2023, 08:31 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerMay 01, 2023Sale$2.58455,5281,173,39515,976,784May 03, 2023, 07:48 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerFeb 01, 2023Sale$2.56413,1681,056,55316,432,312Feb 03, 2023, 06:19 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerDec 20, 2022Sale$2.12600,0001,269,06016,845,480Dec 21, 2022, 04:05 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerNov 01, 2022Sale$1.60468,016749,78117,458,640Nov 03, 2022, 04:05 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 09, 2022Sale$1.75600,0001,050,00014,313,496Aug 11, 2022, 09:45 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 01, 2022Sale$0.67468,024315,10614,926,664Aug 03, 2022, 04:10 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerMay 03, 2022Sale$0.5012,5126,20115,381,520May 05, 2022, 07:18 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerMay 01, 2022Option Exercise$0.52432,128225,78715,394,032May 03, 2022, 08:18 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerFeb 01, 2022Option Exercise$0.77422,096323,79216,124,896Feb 03, 2022, 05:54 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerFeb 02, 2022Sale$0.7610,4167,87715,826,160Feb 03, 2022, 05:54 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerNov 01, 2021Option Exercise$0.64454,848291,10316,001,536Nov 03, 2021, 07:51 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerNov 02, 2021Sale$0.6510,4166,72115,991,120Nov 03, 2021, 07:51 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 02, 2021Sale$0.7710,4167,98916,456,384Aug 03, 2021, 09:45 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerAug 01, 2021Option Exercise$0.79454,840357,04916,466,800Aug 03, 2021, 09:45 PM
VRNAVerona Pharma plcHahn Mark WChief Financial OfficerMar 01, 2021Sale$1.1426,72830,57119,054,504Mar 03, 2021, 08:05 PM
DOVADova Pharmaceuticals Inc.Hahn Mark WChief Financial OfficerSep 30, 2019Sale$28.0077521,7009,024Oct 02, 2019, 04:20 PM
DOVADova Pharmaceuticals Inc.Hahn Mark WChief Financial OfficerJul 01, 2019Sale$14.171,54521,8939,799Jul 02, 2019, 04:59 PM
DOVADova Pharmaceuticals Inc.Hahn Mark WChief Financial OfficerDec 19, 2018Buy$6.282,50015,7002,500Dec 21, 2018, 05:05 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe